Livzon Pharmaceutical Group Inc. (HKG:1513)

HKG:1513 Revenue

Livzon Pharmaceutical Group had revenue of 3.09B CNY in the quarter ending June 30, 2025, with 1.71% growth. This brings the company's revenue in the last twelve months to 11.80B, down -1.83% year-over-year. In the year 2024, Livzon Pharmaceutical Group had annual revenue of 11.81B, down -4.97%.

• Revenue (ttm): 11.80B CNY
• Revenue Growth: -1.83%
• P/S Ratio: 2.72
• Revenue / Employee: 1.30M CNY
• Employees: 9,067
• Market Cap: 35.15B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.81B	-617.70M	-4.97%
Dec 31, 2023	12.43B	-199.54M	-1.58%
Dec 31, 2022	12.63B	565.72M	4.69%
Jan 1, 2022	12.06B	1.54B	14.67%
Jan 1, 2021	10.52B	1.14B	12.10%